Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
June 29th, 2020
15.6K views
We present a complete protocol for postmortem diagnosis of animal rabies under field conditions using a rapid immunochromatographic diagnostic test (RIDT), from brain biopsy sampling to final interpretation. We also describe further applications using the device for molecular analysis and viral genotyping.
Overview
This article presents a protocol for the postmortem diagnosis of animal rabies using a rapid immunochromatographic diagnostic test (RIDT). The procedure includes brain biopsy sampling and interpretation, with additional applications for molecular analysis and viral genotyping.
Key Study Components
Area of Science
- Veterinary diagnostics
- Virology
- Molecular biology
Background
- Rabies is a critical zoonotic disease affecting animals and humans.
- Traditional diagnostic methods may be limited in rural areas.
- The RIDT offers a rapid and effective alternative for rabies diagnosis.
- Field conditions often lack access to reference materials for diagnosis.
Purpose of Study
- To provide a reliable protocol for diagnosing animal rabies postmortem.
- To demonstrate the effectiveness of RIDT in various settings.
- To explore additional applications such as viral genotyping.
Methods Used
- Collection of brain stem samples from animals.
- Use of RIDT for rapid diagnosis.
- RNA extraction and reverse transcriptase quantitative PCR assays.
- Genotyping of rabies virus samples.
Main Results
- The RIDT demonstrated high sensitivity and specificity over 95%.
- Successful collection of brain biopsies was achieved using simple tools.
- Genotyping was performed on a subset of samples.
- The protocol is suitable for field use in resource-limited settings.
Conclusions
- The RIDT provides a quick and accurate method for rabies diagnosis.
- This protocol can enhance rabies surveillance and control efforts.
- It is crucial for maintaining public health and safety.
Frequently Asked Questions
What is the RIDT?
The RIDT is a rapid immunochromatographic diagnostic test used for diagnosing rabies.
How is the brain sample collected?
A brain stem sample is collected using tools like a pipette or straw after removing the animal's head.
What are the key steps in the RIDT process?
Key steps include sample collection, preparation of the suspension, and reading the test results.
What does a positive test result indicate?
A positive result shows two lines on the test device, indicating the presence of rabies antigens.
Can this method be used in rural areas?
Yes, the RIDT is designed for use in field conditions, especially in resource-limited settings.
What is the significance of genotyping?
Genotyping helps identify the specific strain of the rabies virus, which is important for epidemiological studies.
Executive Industry Relevance
Rapid immunochromatographic diagnostic tests (RIDTs) enable decentralized rabies surveillance in resource-limited settings, addressing critical gaps in zoonotic disease monitoring. By combining point-of-care antigen detection with downstream molecular genotyping from inactivated test strips, the protocol supports both immediate outbreak response and longitudinal viral tracking. This dual-capability approach enhances predictive confidence in early-stage target validation for antiviral interventions while reducing reliance on centralized laboratory infrastructure.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional interrogation of lyshostatic mechanisms through rapid confirmation of rabies antigen presence in neural tissue.
- Operational Value: Facilitates high-throughput sampling in field conditions to de-risk target engagement hypotheses in vivo.
Screening & Assay Development
- Scientific Value: Provides standardized, qualitative antigen detection with visual readout for assay normalization across diverse sample types.
- Operational Value: Generates inactivated test strips suitable for safe transport and molecular analysis, enabling workflow continuity from screening to genotyping.
Translational & Preclinical Research
- Scientific Value: Supports viral genotyping via RNA extraction from test strips, linking phenotypic diagnosis to strain-specific molecular characterization.
- Operational Value: Creates a bridge between field surveillance and centralized lab analysis, improving translational continuity in zoonotic pathogen studies.
Pipeline & Workflow Integration
The RIDT protocol integrates into discovery workflows by enabling initial hypothesis testing in endemic regions, with outputs feeding into lead identification through viral strain tracking.
- Discovery Biology: Supports target validation by confirming rabies antigen expression in brain biopsies, clarifying pathophysiological relevance of neural invasion mechanisms.
- Screening: Delivers reproducible, instrument-free antigen detection with defined positivity criteria (two visible lines) for scalable sample triage.
- Analytics: Enables quantitative downstream analysis via RNA extraction and RT-qPCR, providing measurable outputs for viral load and genotyping correlations.
- Translational Research: Connects field-based diagnosis to preclinical modeling through genotyping data that informs strain selection for vaccine or therapeutic evaluation.
- Enterprise Reuse: Establishes a portable diagnostic module adaptable to other lyssaviruses, maximizing platform utility across multiple R&D programs.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in zoonotic pathogenesis by enabling rapid confirmation of viral presence in target tissues.
- Operational Value: Eliminates need for cold chain or specialized equipment, standardizing sample processing across geographically dispersed sites.
- Strategic Value: Accelerates go/no-go decisions in antiviral programs by providing early, reliable evidence of target modulation in vivo.
- Portfolio Impact: Improves risk-adjusted prioritization through accessible surveillance data that informs geographic and strain-specific investment strategies.
Implementation Considerations
- Requires training in proper brainstem sampling technique to ensure medulla oblongata collection for diagnostic accuracy.
- Depends on access to basic sample preparation tools (pipettes, tubes, buffer) and lateral flow readers for consistent results.
- Necessitates standardization of RNA extraction protocols from test strips to maintain genotyping reliability across laboratories.
- Involves adaptation considerations for non-rabies lyssaviruses due to potential variations in antigen concentration and test line visibility.
- Limited by the visual detection threshold of the assay, which may require confirmatory testing in low-antigen samples despite high analytical sensitivity post-extraction.
Biopharma FAQs
Why does visual line detection matter for rabies target validation?
The presence of two visible lines on the RIDT strip confirms rabies antigen binding, providing a direct readout of target engagement in neural tissue. This visual output enables rapid hypothesis testing in field settings without instrumentation. It supports early-stage target validation by offering immediate, binary evidence of viral presence in collected samples.
How does brainstem sampling isolation improve discovery pipeline specificity?
Focusing on brainstem collection, particularly the medulla oblongata, increases the likelihood of detecting rabies antigens due to high viral replication in this region. This targeted sampling reduces false negatives and enhances assay reliability. It ensures that downstream molecular analysis reflects biologically relevant tissue rather than heterogeneous brain homogenates.
What quantitative measurements does RNA extraction from the test strip enable?
RNA extraction from the inactivated RIDT strip allows for quantitative viral load measurement via RT-qPCR assays. This provides a measurable output for assessing infection severity and tracking viral dynamics over time. It enables correlation between antigen detection levels and genomic copy number for improved predictive modeling.
Why do replication requirements matter for cross-functional collaboration in zoonotic surveillance?
Replicating RIDT results across multiple field sites and laboratories builds confidence in the test’s reliability under varying environmental and operator conditions. Consistent replication supports standardized data sharing between veterinary, public health, and research teams. It ensures that genotyping data derived from test strips are comparable and suitable for integrated epidemiological databases.
What statistical analysis capabilities are required before implementing RIDT for preclinical decision-making?
Implementation requires sensitivity and specificity analysis against gold standard methods like direct immunofluorescence antibody testing to establish performance thresholds. Teams must define positivity criteria (e.g., two-line visibility) and calculate confidence intervals for diagnostic accuracy. These statistical outputs inform go/no-go criteria for using RIDT data in target validation or lead selection pipelines.
